Artykuły udostępnione publicznie: - Lilian Abbo, M.D.Więcej informacji
Niedostępne w żadnym miejscu: 2
Opportunities to improve antibiotic appropriateness in US ICUs: a multicenter evaluation
KK Trivedi, R Bartash, AR Letourneau, L Abbo, J Fleisher, C Gagliardo, ...
Critical care medicine 48 (7), 968-976, 2020
Upoważnienia: US Department of Veterans Affairs
Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre‐and post‐direct‐acting antiviral therapy eras: 10‐Year single center experience
JF Camargo, S Anjan, N Chin‐Beckford, MI Morris, LM Abbo, J Simkins, ...
Clinical transplantation 33 (5), e13532, 2019
Upoważnienia: US National Institutes of Health
Dostępne w jakimś miejscu: 37
Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
TF Barlam, SE Cosgrove, LM Abbo, C MacDougall, AN Schuetz, ...
Clinical infectious diseases 62 (10), e51-e77, 2016
Upoważnienia: US National Institutes of Health
Research methods in healthcare epidemiology: survey and qualitative research
N Safdar, LM Abbo, MJ Knobloch, SK Seo
Infection control & hospital epidemiology 37 (11), 1272-1277, 2016
Upoważnienia: US National Institutes of Health, US Department of Veterans Affairs
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective …
M Wang, M Earley, L Chen, BM Hanson, Y Yu, Z Liu, S Salcedo, E Cober, ...
The Lancet Infectious Diseases 22 (3), 401-412, 2022
Upoważnienia: US National Institutes of Health, US Department of Veterans Affairs …
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study
J Reyes, L Komarow, L Chen, L Ge, BM Hanson, E Cober, E Herc, ...
The Lancet Microbe 4 (3), e159-e170, 2023
Upoważnienia: US National Institutes of Health
Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa
JM Munita, SL Aitken, WR Miller, F Perez, R Rosa, LA Shimose, ...
Clinical Infectious Diseases 65 (1), 158-161, 2017
Upoważnienia: US National Institutes of Health, US Department of Veterans Affairs
Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized …
MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ...
Jama 327 (5), 432-441, 2022
Upoważnienia: US National Institutes of Health
Knowledge and attitudes of doctor of pharmacy students regarding the appropriate use of antimicrobials
JA Justo, TP Gauthier, MH Scheetz, EB Chahine, PB Bookstaver, ...
Clinical Infectious Diseases 59 (suppl_3), S162-S169, 2014
Upoważnienia: US National Institutes of Health
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists …
L Papst, B Beović, C Pulcini, E Durante-Mangoni, J Rodríguez-Baño, ...
Clinical Microbiology and Infection 24 (10), 1070-1076, 2018
Upoważnienia: European Commission
Current state of antimicrobial stewardship at solid organ and hematopoietic cell transplant centers in the United States
SK Seo, K Lo, LM Abbo
infection control & hospital epidemiology 37 (10), 1195-1200, 2016
Upoważnienia: US National Institutes of Health
The Global Alliance for Infections in Surgery: defining a model for antimicrobial stewardship—results from an international cross-sectional survey
M Sartelli, FM Labricciosa, P Barbadoro, L Pagani, L Ansaloni, AJ Brink, ...
World journal of emergency surgery 12, 1-11, 2017
Upoważnienia: US National Institutes of Health
In Vitro Discordance with In Vivo Activity: Humanized Exposures of Ceftazidime-Avibactam, Aztreonam, and Tigecycline Alone and in Combination against New …
ML Monogue, LM Abbo, R Rosa, JF Camargo, O Martinez, RA Bonomo, ...
Antimicrobial agents and chemotherapy 61 (7), 10.1128/aac. 00486-17, 2017
Upoważnienia: US National Institutes of Health, US Department of Veterans Affairs
A global declaration on appropriate use of antimicrobial agents across the surgical pathway
Global Alliance for Infections in Surgery Working Group
Surgical infections 18 (8), 846-853, 2017
Upoważnienia: US Department of Veterans Affairs, Helmholtz Association, National Institute …
Real-world, multicenter experience with meropenem-vaborbactam for gram-negative bacterial infections including carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa
S Alosaimy, AM Lagnf, T Morrisette, MR Scipione, JJ Zhao, ...
Open forum infectious diseases 8 (8), ofab371, 2021
Upoważnienia: US National Institutes of Health
How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers
AJ Sundermann, CJ Clancy, AW Pasculle, G Liu, RB Cumbie, E Driscoll, ...
Clinical Infectious Diseases 68 (5), 850-853, 2019
Upoważnienia: US National Institutes of Health
Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus–Infected Kidney Allograft Recipients
JF Suarez, R Rosa, MA Lorio, MI Morris, LM Abbo, J Simkins, G Guerra, ...
American Journal of Transplantation 16 (8), 2463-2472, 2016
Upoważnienia: US National Institutes of Health
Linezolid- and Vancomycin-resistant Enterococcus faecium in Solid Organ Transplant Recipients: Infection Control and Antimicrobial Stewardship Using Whole …
L Abbo, BS Shukla, A Giles, L Aragon, A Jimenez, JF Camargo, J Simkins, ...
Clinical Infectious Diseases 69 (2), 259-265, 2019
Upoważnienia: US National Institutes of Health
Antimicrobial stewardship training for infectious diseases fellows: program directors identify a curriculum need
VP Luther, R Shnekendorf, LM Abbo, S Advani, WS Armstrong, ...
Clinical infectious diseases 67 (8), 1285-1287, 2018
Upoważnienia: US National Institutes of Health
Contemporary clinical and molecular epidemiology of vancomycin-resistant enterococcal bacteremia: a prospective multicenter cohort study (VENOUS I)
GA Contreras, JM Munita, S Simar, C Luterbach, AQ Dinh, K Rydell, ...
Open forum infectious diseases 9 (3), ofab616, 2022
Upoważnienia: US National Institutes of Health
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy